{
     "PMID": "29373545",
     "OWN": "NLM",
     "STAT": "In-Process",
     "LR": "20180126",
     "IS": "1422-0067 (Electronic) 1422-0067 (Linking)",
     "VI": "19",
     "IP": "2",
     "DP": "2018 Jan 26",
     "TI": "Growth Hormone (GH) and Gonadotropin-Releasing Hormone (GnRH) in the Central Nervous System: A Potential Neurological Combinatory Therapy?",
     "LID": "E375 [pii] 10.3390/ijms19020375 [doi]",
     "AB": "This brief review of the neurological effects of growth hormone (GH) and gonadotropin-releasing hormone (GnRH) in the brain, particularly in the cerebral cortex, hypothalamus, hippocampus, cerebellum, spinal cord, neural retina, and brain tumors, summarizes recent information about their therapeutic potential as treatments for different neuropathologies and neurodegenerative processes. The effect of GH and GnRH (by independent administration) has been associated with beneficial impacts in patients with brain trauma and spinal cord injuries. Both GH and GnRH have demonstrated potent neurotrophic, neuroprotective, and neuroregenerative action. Positive behavioral and cognitive effects are also associated with GH and GnRH administration. Increasing evidence suggests the possibility of a multifactorial therapy that includes both GH and GnRH.",
     "FAU": [
          "Martinez-Moreno, Carlos G",
          "Calderon-Vallejo, Denisse",
          "Harvey, Steve",
          "Aramburo, Carlos",
          "Quintanar, Jose Luis"
     ],
     "AU": [
          "Martinez-Moreno CG",
          "Calderon-Vallejo D",
          "Harvey S",
          "Aramburo C",
          "Quintanar JL"
     ],
     "AD": "Departamento de Neurobiologia Celular y Molecular, Instituto de Neurobiologia, Campus Juriquilla, Universidad Nacional Autonoma de Mexico, Boulevard Juriquilla 3001, Queretaro 76230, Mexico. cgmartin@comunidad.unam.mx. Departamento de Fisiologia y Farmacologia, Centro de Ciencias Basicas, Universidad Autonoma de Aguascalientes, Av. Universidad 940, Ciudad Universitaria, Aguascalientes 20131, Mexico. dcalderon@correo.uaa.mx. Department of Physiology, University of Alberta, Edmonton, AB T6G 2H7, Canada. steve.harvey@ualberta.ca. Departamento de Neurobiologia Celular y Molecular, Instituto de Neurobiologia, Campus Juriquilla, Universidad Nacional Autonoma de Mexico, Boulevard Juriquilla 3001, Queretaro 76230, Mexico. aramburo@unam.mx. Departamento de Fisiologia y Farmacologia, Centro de Ciencias Basicas, Universidad Autonoma de Aguascalientes, Av. Universidad 940, Ciudad Universitaria, Aguascalientes 20131, Mexico. jlquinta@correo.uaa.mx.",
     "AUID": [
          "ORCID: 0000-0002-6235-8695"
     ],
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Review"
     ],
     "DEP": "20180126",
     "PL": "Switzerland",
     "TA": "Int J Mol Sci",
     "JT": "International journal of molecular sciences",
     "JID": "101092791",
     "OTO": [
          "NOTNLM"
     ],
     "OT": [
          "CNS",
          "GH",
          "GnRH",
          "extrahypothalamic",
          "extrapituitary",
          "neuroprotection",
          "neuroregeneration",
          "neurotrophic",
          "therapy"
     ],
     "COIS": [
          "The authors declare no conflicts of interest."
     ],
     "EDAT": "2018/01/27 06:00",
     "MHDA": "2018/01/27 06:00",
     "CRDT": [
          "2018/01/27 06:00"
     ],
     "PHST": [
          "2017/12/30 00:00 [received]",
          "2018/01/21 00:00 [revised]",
          "2018/01/23 00:00 [accepted]",
          "2018/01/27 06:00 [entrez]",
          "2018/01/27 06:00 [pubmed]",
          "2018/01/27 06:00 [medline]"
     ],
     "AID": [
          "ijms19020375 [pii]",
          "10.3390/ijms19020375 [doi]"
     ],
     "PST": "epublish",
     "SO": "Int J Mol Sci. 2018 Jan 26;19(2). pii: ijms19020375. doi: 10.3390/ijms19020375.",
     "term": "hippocampus"
}